Regulatory T cells can restrict the uncontrolled immune response and inflammation, avoiding pathologic immune injury to the host and thus playing important roles in the maintenance of immune homeostasis. Until recently, many subsets of CD4 and CD8 regulatory T cells have been reported. In this study, we identified 
R egulatory T cells (Tregs) have important roles in the maintenance of immune homeostasis and in fine regulation of immune responses against infection and tumor (1-4)
. In addition to the immunosuppressive effects of Tregs in the chronic infection-and tumor-bearing host, Tregs are important in the negative regulation of immune response at the late stage, limiting the magnitude of the immune response and contributing to avoid self-tissue damage caused by a vigorous immune response (5) . According to their origin, development, and mechanism of action, CD4 Tregs can be divided into two main subsets: natural Foxp3 + Tregs (nTregs) and induced Tregs (iTregs), which include IL-10-producing T regulatory 1 cells, TGF-b-producing Tregs and induced Foxp3 + Tregs (6, 7) . Both nTreg cells and iTregs have been shown to play important roles in the immunity against infection (5) . Immunosuppressive functions of Tregs can be mediated by immunosuppressive cytokines, such as IL-10 and TGFb, by cell-cell direct contact of suppressor cells with effector cells, or by instructing dendritic cells (DCs) to increase tryptophan metabolism or secrete suppressive cytokines (8) . We previously also identified a novel tumor-induced CD69 + CD25 2
CD4
+ regulatory T cell subset, which suppresses antitumor immune response through membrane-bound TGF-b (9) . Several CD8 Tregs have been discovered and functionally analyzed, such as Qa-1/HLA-E-restricted CD8 Tregs (10) (11) (12) (19) , and CD8 + CD45RC low Tregs (20) . However, comprehensive studying of CD8 Tregs is hindered by a lack of specific common markers and key transcription factors. In addition, there might be a new subset of CD8 Tregs at the late stage of immune response, which is helpful to avoid overactivation of the immune response and help to balance the immune system, which needs to be identified further and functionally investigated.
CD11c, the aX subunit of the aXb2 (CD11c/CD18) integrin, is the first DC marker to be identified and has been instrumental in the identification and characterization of DC subsets (21) . In addition to DCs, some subset of CD8 T cells was reported to express CD11c (22) . CD8 T cells expressing CD11c was first reported in 1987, when it was observed that CD11c was expressed by some human CTL clones and was involved in cell-mediated cytolysis by these clones (23) . CD11c + CD8 + T cells were a subset of activated, Ag-specific, cytotoxic T cells that exhibited potent antiviral effects in vitro and in vivo (24) . Therefore, it seems that CD11c is an activated marker of CD8 T cells and that CD11c + CD8 + T cells can serve as CTLs. However, CD11c + CD8 + T cells-induced and expanded by inoculation of agonistic anti-4-1 BB mAb in collagen type II-induced arthritis mice (25) , experimental autoimmune uveoretinitis mice (26) , and hapten-induced colitis mice (27)-were found to be regulatory T cells that suppressed Ag-specific CD4 T cells through an IDO-dependent mechanism. In addition, CD11c + CD8 + T cells in small intestine, but not in large intestine, were recently identified as a distinct intestinal regulatory T cell population to control proinflammatory CD4 T cells and maintain intestinal mucosal homeostasis (28) 
Material and Methods
Mice C57BL/6 mice were obtained from Joint Ventures Sipper BK Experimental Animal Co. (Shanghai, China) and used at the age of 6-8 wk. The OVAspecific TCR transgenic OT-I mice and DO11.10 mice, FasL-deficient mice, and perforin-deficient mice on a C57BL/6 background were obtained from The Jackson Laboratory and bred in specific pathogen-free conditions. All experimental manipulations were undertaken in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, with the approval of the Scientific Investigation Board of the Second Military Medical University, Shanghai, China.
Reagents
The Abs for flow cytometry, including Abs against CD11c (N418), CD69 (1H.2F3), CD25 (PC61), CD122 (5H4), CD44 (IM7), CD62L (MEL-14), TCR DO11.10 (KJ1-26), IL-4 (11B11), IL-10 (JES5-16E3), IFN-g (XMG1.2), TGF-b (2Ar2), CD8 (53-6.7), TCR-b (H57-597), neutralizing anti-CD11c (N418) and anti-FasL (MFL3) mAb, and activating anti-CD3 (145-2C11) and anti-CD28 (37.51) mAbs were obtained from BD Pharmingen. PMA, ionomycin, and OVA 323-339 were obtained from SigmaAldrich (St. Louis, MO). Intracellular staining kits and ELISA kits were obtained from R&D Systems. 7-Aminoactinomycin D and CFSE were obtained from Invitrogen.
Bacterial infections and quantification
L. monocytogenes strain (rLM6) and OVA-transfected L. monocytogenes strain (LmOVA) were provided by Dr. Hao Shen (University of Pennsylvania School of Medicine, Philadelphia, PA). Bacteria were grown overnight in brain-heart infusion broth, washed twice with PBS, aliquoted in PBS 10% glycerol, frozen, and stored at 280˚C. Aliquots were thawed, and bacterial titers were determined by plating serial dilutions on brainheart infusion broth agar plates. For infection, aliquots were thawed and appropriately diluted in PBS, and 1 3 10 4 bacteria were injected in a volume of 200 ml PBS into the lateral tail veins of mice as described previously (29) . Bacteria in the spleen and liver were measured at the appropriate time after infection by homogenization and lysis of tissues in 5 ml of 0.05% (v/v) Triton X-100, followed by plating onto brain-heart infusion plates. Total colonies per liver or spleen were counted after incubation overnight at 37˚C (29, 30) .
Staphylococcus aureus strain FDA209 (6538) was obtained from American Type Culture Collection (Manassas, VA). For infection, aliquots were thawed and appropriately diluted in PBS, and 1 3 10 6 bacteria were injected in a volume of 150 ml PBS into the lateral tail veins of mice as described previously (31) .
Assay for intracellular cytokine expression by FACS
For intracellular staining, cells were stimulated with 25 ng/ml PMA and 1 mg/ml ionomycin for 24 h at 37˚C, and brefeldin A (10 mg/ml) was included for the last 6 h of incubation. Cells were collected and stained with the Abs against cell-surface Ags, and then fixed and permeabilized with the Cytofix/Cytoperm kit according to the manufacturer's instructions (eBioscience). The cells were washed with permeabilization buffer and labeled with PE-conjugated anti-IFN-g, anti-IL-4, anti-IL-10, anti-TGFb1 mAbs or the respective isotype controls. Flow cytometry was done with a FACS LSRII, and data were analyzed with FACSDiva software (BD Biosciences). 
Isolation and purification of

CD69
+ T cells were purified from naive splenic CD4 T cells (isolation by MACS) after activated in vitro for 5 d with IL-2 (500 U/ml), anti-CD3 (10mg/ml) mAb and anti-CD28 (2mg/ ml) mAb. Before cocultured with CD8 T cell subsets, purified CD4 + KJ1-26 + T cells were stimulated with IL-2 (500 U/ml) and OVA 323-339 peptides (20 ng/ml) for 2 h at 37˚C.
Assay for cytotoxicity of CD8 T cell subsets in vitro
CD11c
high CD8 + T cells, CD11c low CD8 + T cells and CD11c -CD8 + T cells were seeded at 5 3 10 5 cells/well in 96-well plates respectively, and incubated with OVA-transfected EL4 target cells (EG7) or activated CD4 T cells for 6 h at 37˚C at the indicated E:T ratio. In some experiments, neutralizing anti-FasL mAb or anti-CD11c mAb were included in the coculture system. The cytotoxicity of CD8 T cell subsets against EG7 target cells or activated CD4 T cells was measured using flow cytometry as previously described (32, 33) . Cells were collected, stained with 7-aminoactinomycin D and analyzed by FACS LSRII. Live target cells were determined by gating on CD8 -
7AAD
-populations. Percentage of cytotoxicity was calculated by the following equation:
Assay for cytotoxicity of CD8 T cell subsets in vivo
In vivo cytotoxicity assay of CD8 T cell subsets was performed as previously described (34) 
Detection of cytokines by ELISA
For detection of IFN-g, IL-6, or TNF-a secretion, cell supernatants or serum were collected, and the cytokine concentrations were determined by ELISA kits according to the manufacturer's instructions (R&D).
Statistical analysis
Data were analyzed for statistical significance using Student t test. Statistical significance was determined as p , 0.05.
Results
Generation of CD11c high CD8 + T cells after L. monocytogenes infection
For analyzing the functions of diverse CD8 T cell subsets in bacterial infection, we infected mice with L. monocytogenes and then analyzed the variation of splenic CD8 T cells at different times. Among the phenotype markers of T cells, the expression of CD11c on splenic CD8 T cells attracted our attention. Splenic CD8 T cells from normal C57BL/6 mice barely express CD11c (Fig. 1A) . After infection of L. monocytogenes, the expression of CD11c on splenic CD8 T cells was low but increased. About 21.5% CD8 T cells expressed CD11c on day 6. However, the proportion of CD11c + CD8 + T cells significantly increased to ∼62.9% on day 8. Next, the proportion of CD11c + CD8 + T cells declined, to ∼19.4% on day 10, and maintained at ∼10% on day 12 after infection ( Fig. 1A, 1B) .
Interestingly, we also found that the expression level of CD11c on splenic CD8 T cells on day 8 was much higher than that at other days, and obviously there was a subset of CD11c high CD8 + T cells on day 8 (Fig. 1A) (35) . Therefore, we confirmed that these CD11c high CD8 + cells were CD8 T cells, not CD8 + DCs. To confirm the validity of our L. monocytogenes infection model, we determined the bacterial burdens in the spleen and liver at different times after infection. As shown in Fig. 1C , the bacterial titers in the spleen and liver peaked on day 2 of infection, and then it declined. The bacteria in the spleen were completely eliminated on day 8, whereas the bacteria in the liver were completely eliminated on day 12. These data revealed that CD11c + T cells are restricted to L. monocytogenes infection, we created the murine model of metastatic chronic osteomyelitis initiated after i.v. inoculation of S. aureus microorganism, which mimics human osteomyelitis caused by S. aureus (31) . We found that S. aureus infection also induced CD11c high CD8 + T cells that appeared on day 20 after infection and disappeared on day 30 ( Fig. 2A) . Although these cells maintained much longer in S. aureus infection than that in L. monocytogenes infection, the proportion of CD11c high CD8 + T cells in splenic CD8 T cells in S. aureus infection (∼6%; Fig.  2A ) was much lower than in L. monocytogenes infection (∼50%) ( Fig. 1A) . As a result, we chose L. monocytogenes-infected mice to study CD11c high CD8 + T cells further. To confirm the validity of our S. aureus-infection model, we detected IL-6 and TNF-a concentrations in the serum at different times after infection. As shown in Fig. 2B and 2C, the concentrations of IL-6 and TNF-a in the serum peaked on day 10 of infection and then declined. On day 35 after infection, their concentrations declined to the normal levels; therefore, we confirmed that in the S. aureus infection process, CD11c high CD8 + T cells only induced and maintained at the late stage of antiinfection immune response, whereas CD11c low CD8 + T cells existed during the whole period of infection, just as in the L. monocytogenes infection process. + T cells. We found that there was no obvious difference in the expression of CD44 and CD62L (Fig. 3A, 3C ), CD25 and CD28 (data not shown), between IFN-g (Fig. 4A) . None of these three CD8 T cell subsets expressed IL-4, IL-10, or TGF-b (data not shown). ELISA assay of IFN-g secretion by these CD8 T cell subsets was performed to confirm the results of intracellular staining. The supernatants from purified CD11c + T cells didn't secrete IFN-g with or without stimulation (Fig. 4B) + T cells displayed moderate cytotoxicity against EG7 target cells (Fig. 4C) . Interestingly, CD11c high CD8 + T cells possessed much more potent cytotoxicity against EG7 target cells, and the percentage of lysis reached 80% at the 40:1 E:T ratio (Fig. 4C) .
We further analyzed the cytotoxic mechanism of these CD8 T cell subsets. As shown in Fig. 5 
CD8
+ T cells expressed higher FasL (∼16%). After culture alone in vitro for 6 h, the expression levels of FasL of these CD8 T cell subsets remained unchanged (Fig. 6A) + T cells was not affected (Fig. 6B) ). Cytotoxicity against EG7 target cells was measured by flow cytometry. Means 6 SEM (n = 3; 5 mice per group). *p . 0.05, **p , 0.05, ***p , 0.01. purified from splenocytes of LmOVA-infected OT-I mice (day 8 
+ T cells possessed potent cytotoxicity, although the percentage of lysis was only ∼70% at the 40:1 E:T ratio (Fig. 7B) . Together, these data demonstrate that CD11c high CD8
+ T cells can kill the activated CD4 T cells in vitro in an Agindependent manner.
Because (Fig. 7C) , much lower than that needed to kill EG7 cells (∼80%), suggesting that the Ag might also have a role in the cytotoxicity process. 7D) . The percentage of lysis showed a time-dependent effect, increasing from ∼45% after 1 h after transfer to ∼80% after 3 h (Fig. 7E) . In contrast, the activated CD4 T cells were not obvi- ously decreased after transfer of CD11c low CD8 + or CD11c 2 CD8 + T cells (Fig. 7D, 7E) . Therefore, the data suggest that CD11c 
Discussion
To study the functions of diverse CD8 T cell subsets in bacterial infection, we analyzed the variation of phenotypes and functions of CD8 T cells in the spleens of the mice with L. monocytogenes infection. We found that splenic CD8 T cells from the L. monocytogenes-infected mice began to express CD11c with peak expression of CD11c on day 8 + regulatory T cells both inhibit immune response by directly killing CD4 T cells, these two CD8 T cell populations are hardly the same subset. First, Qa-1-restricted CD8 regulatory T cells are naturally occurring cells, whereas CD11c high CD8 + regulatory T cells are infection induced; second, the former kills CD4 T cells by perforin, and the latter kills CD4 T cells via FasL-Fas pathway; third, the main function of the former is to maintain self-tolerance, and the main function of the latter is to downregulate immune response at the late stage of infection (10, 37) . Recently, glatiramer acetate was found to ameliorate inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8 regulatory T cells, whose suppressive activity depended on perforin-mediated cytotoxicity against pathogenic CD4 T cells (38) . Moreover, novel human regulatory CD8 T cell clones were isolated from healthy human peripheral blood following in vitro stimulation with autologous EBV-specific CD4 T cells, whose suppressive activity was mediated through lysis of target CD4 T cells in a cell-contactdependent manner (39) . Therefore, CD4 T cell-killing, regulatory CD8 T cells exist in mice and humans. In addition, both human CD4 nTregs and iTregs exhibit perforin-dependent cytotoxicity against a variety of autologous target cells, including CD4 and CD8 T cells, monocytes, and DCs (40, 41 
CD8
+ T cell subset; therefore, most reports found that CD11c + CD8 + T cells served as conventional activated CD8 T cells (22) (23) (24) . For example, it was found that CD11c + CD8 + T cells possess higher levels of LCMVspecific killing activity than CD11c 2 CD8 + T cells (42); anti-4-1BB mAb administration to B16F10 melanoma-bearing mice induced potent expansion of CD11c + CD8 + T cells in parallel with suppression of tumors (43, 44) . However, CD11c high CD8 + T cells might be induced and expanded only in unique conditions, such as on day 8 of L. monocytogenes infection in this study, or after agonistic anti-4-1 BB mAb inoculation in autoimmune or inflammatory disorders (25) (26) (27) .
CD11c/CD18, also known as aXb2, p150/95 and complement receptor 4 (CR4), belongs to b2 integrin family, which also includes CD11a/CD18, CD11b/CD18, and CD11d/CD18 (21) . CD11c binds to soluble and matrix ligands including iC3b, LPS, fibrinogen, and collagen, and cellular ligands including ICAM-1, ICAM-2, ICAM-4, VCAM-1, and Thy-1 (45, 46) . CD11c/CD18 has an important role in phagocytosis, chemotaxis, and regulation of immune response (45) . However, it remains to be seen whether the ligation of CD11c on effector cells and its ligands on target cells has an important role in cytotoxicity of CTLs. It was demonstrated that mAb directly against CD11c could inhibit the cytotoxic activity of two human CTL clones (23) , whereas incubation with mAb had no effect on the cytotoxicity of CD11c + CD8 + T cells from mice infected with respiratory syncytial virus (24) . In this study, we demonstrate that blockade of CD11c ligation with its ligands inhibits the cytotoxic activity of both + T cells kill the activated CD4 T cells in an Ag-independent fashion, the ligation of Ag and TCR could also have a role in the cytotoxicity of CD11c high CD8 + T cells, at least enhancing the cytotoxic ability. We found that the cytotoxic ability of CD11c high CD8
+ T cells against Ag-specific target cells (∼90%) was stronger than that against Ag-nonspecific target cells (∼70%). Furthermore, we also found that CD11c high CD8
+ T cells could kill EL4 cells (∼35%), and the ability was lower than that to kill EG7 target cells (∼80%), which also supports our hypothesis.
In summary, we have identified a new subset of CD11c high CD8 + regulatory T cells that was induced and expanded at the late stage of L. monocytogenes and S. aureus infection. Although there was no secretion of IFN-g, IL-10, or TGF-b, the new CD8 regulatory T cell subset possesses potent cytotoxicity to target cells via the FasL-Fas pathway, and it inhibits CD4 T cell immune response by killing the activated CD4 T cells.
